142 related articles for article (PubMed ID: 20394542)
1. Comparing anatomical pattern of topical anti-glaucoma medications associated lacrimal obstruction with a control group.
Kashkouli MB; Pakdel F; Hashemi M; Ghaempanah MJ; Rezaee R; Kaghaz-Kanani R; Ahadian A
Orbit; 2010 Apr; 29(2):65-9. PubMed ID: 20394542
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative mitomycin C use during filtration surgery and lacrimal drainage system obstruction.
Kashkouli MB; Parvaresh MM; Mirzajani H; Astaraki A; Falavarjani KG; Ahadian A
Am J Ophthalmol; 2009 Mar; 147(3):453-457.e1. PubMed ID: 19019341
[TBL] [Abstract][Full Text] [Related]
3. Topical antiglaucoma medications and lacrimal drainage system obstruction.
Kashkouli MB; Rezaee R; Nilforoushan N; Salimi S; Foroutan A; Naseripour M
Ophthalmic Plast Reconstr Surg; 2008; 24(3):172-5. PubMed ID: 18520829
[TBL] [Abstract][Full Text] [Related]
4. Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction.
Seider N; Miller B; Beiran I
Am J Ophthalmol; 2008 Jan; 145(1):120-123. PubMed ID: 17915187
[TBL] [Abstract][Full Text] [Related]
5. The Micro-Reflux Test: a new test to evaluate nasolacrimal duct obstruction.
Camara JG; Santiago MD; Rodriguez RE; Medalle RA; Young DA; Atebara NH
Ophthalmology; 1999 Dec; 106(12):2319-21. PubMed ID: 10599664
[TBL] [Abstract][Full Text] [Related]
6. Lacrimal canalicular obstruction associated with topical ocular medication.
McNab AA
Aust N Z J Ophthalmol; 1998 Aug; 26(3):219-23. PubMed ID: 9717753
[TBL] [Abstract][Full Text] [Related]
7. Tear meniscus level as an indicator of nasolacrimal obstruction.
Burkat CN; Lucarelli MJ
Ophthalmology; 2005 Feb; 112(2):344-8. PubMed ID: 15691573
[TBL] [Abstract][Full Text] [Related]
8. The relationship between topical anti-glaucoma medications and the development of lacrimal drainage system obstruction.
Ortiz-Basso T; Galmarini A; Vigo RL; Gonzalez-Barlatay JM; Premoli EJ
Arq Bras Oftalmol; 2018 Nov./Dec.; 81(6):490-493. PubMed ID: 30304090
[TBL] [Abstract][Full Text] [Related]
9. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of silicone punctal plugs as adjuncts to topical pharmacotherapy of glaucoma--a pilot study. Punctal Plugs in Glaucoma Study Group.
Bartlett JD; Boan K; Corliss D; Gaddie IB
J Am Optom Assoc; 1996 Nov; 67(11):664-8. PubMed ID: 8979659
[TBL] [Abstract][Full Text] [Related]
11. Lacrimal excretory system concretions: canalicular and lacrimal sac.
Repp DJ; Burkat CN; Lucarelli MJ
Ophthalmology; 2009 Nov; 116(11):2230-5. PubMed ID: 19744730
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic topical glaucoma medications on aerobic conjunctival bacterial flora.
Sen EM; Yilmaz MB; Dansuk Z; Aksakal FN; Altinok A; Tuna T; Koklu G
Cornea; 2009 Apr; 28(3):266-70. PubMed ID: 19387226
[TBL] [Abstract][Full Text] [Related]
13. Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults.
Dolmetsch AM
Ophthalmology; 2010 May; 117(5):1037-40. PubMed ID: 20079535
[TBL] [Abstract][Full Text] [Related]
14. Double lacrimal puncta: clinical presentation and potential mechanisms of epiphora.
Satchi K; McNab AA
Ophthalmology; 2010 Jan; 117(1):180-183.e2. PubMed ID: 19875171
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of primary acquired nasolacrimal duct obstruction.
Kashkouli MB; Sadeghipour A; Kaghazkanani R; Bayat A; Pakdel F; Aghai GH
Orbit; 2010 Feb; 29(1):11-5. PubMed ID: 20302403
[TBL] [Abstract][Full Text] [Related]
16. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
[TBL] [Abstract][Full Text] [Related]
17. The impact of common classes of topical antiglaucoma medications on central corneal thickness--own observations.
Wierzbowska J; Łagocka A; Siemiatkowska A; Robaszkiewicz J; Stankiewicz A; Sierdziński J
Klin Oczna; 2009; 111(10-12):323-6. PubMed ID: 20169887
[TBL] [Abstract][Full Text] [Related]
18. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
[TBL] [Abstract][Full Text] [Related]
19. [The effect of treating obstructive disease of lacrimal passage by lacrimal plastic operation with Nd:YAG laser].
Liu Y; Zhang JS; Ma YL; Hao CF; Xu F; Chen SJ; Li JH; Li M
Zhonghua Yan Ke Za Zhi; 2003 Sep; 39(9):533-6. PubMed ID: 14766083
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant.
Goulet RJ; Phan AD; Cantor LB; WuDunn D
Ophthalmology; 2008 Jul; 115(7):1141-7. PubMed ID: 18164068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
